In perilesional areas, we mostly observed a moderate-strong positivity for CK19, distributed in all epithelial layers (mostly at basal layer) and with lower percentages in HR-HPV− cancers than in HR-HPV+ ones (68.4 % vs 100 %) where the marker preferentially was located to the upper layers. This evidence concerns the gene KRT19 and cancer.